Da Ma: Raises target price of China Life (02628.HK) to 25.7 Hong Kong dollars, rating "buy"

Zhtng Cijng APP learned that Morgan Stanley released a research report stating that after China Life Insurance (02628.HK) announced its first-half financial performance, they have updated their model and increased their earnings forecast for China Life Insurance for the years 2025 to 2027 by 13.1%, 1%, and 1.9% respectively. This is mainly due to the expected rise in the stock market and stable sales growth in the 2025 fiscal year. With the improvement in profit margins, the forecasted new business value for each fiscal year has also increased by 6.6%, 8.1%, and 8.5% respectively. Morgan Stanley has adjusted the target price for China Life Insurance's H shares from 25 Hong Kong dollars to 25.7 Hong Kong dollars, with a "hold" rating.